SCHEMBL8375083

SCHEMBL8375083

CCOC(=O)C(Br)=C(Br)c1ccc(C(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
HTT P42858 1/20 0.43
USP5 P45974 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAOA P21397 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ESR1 P03372 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375080 1.00 LMNA (0.43) LMNASMN1; SMN2HTTUSP5CYP1A2
SCHEMBL8375792 0.84 SMN1; SMN2 (0.50) LMNASMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL8375797 0.84 SMN1; SMN2 (0.50) LMNASMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL11821119 0.80 ALDH1A1 (0.56) LMNASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL2124530 0.80 LMNA (0.48) LMNASMN1; SMN2HTTUSP5CYP1A2
SCHEMBL1054614 0.80 ALDH1A1 (0.56) LMNASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL21065593 0.78 LMNA (0.46) LMNASMN1; SMN2HTTUSP5CYP1A2
SCHEMBL8375832 0.77 NPSR1 (0.51) MEN1KMT2AALDH1A1MAPT
SCHEMBL570567 0.76 LMNA (0.67) LMNASMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL8377288 0.76 NPC1 (0.51) LMNASMN1; SMN2HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed